← Back to Fredun Pharmaceuticals Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

FREDUNPharmaceuticals

Fredun Pharmaceuticals Ltd — Financial Ratios & Key Metrics

₹1671.80

-1.27%

P/E Ratio46.38xIndustry: 31.77x

ROEN/AReturn on equity

ROCEN/AReturn on capital

Debt/Equity1.09High debt

💎

Valuation & Profitability

P/E Ratio

46.38x

Industry Average P/E

31.77x

Dividend Yield

0.04%

Market Cap

₹915.48 (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

N/A

📉

Price Returns

1 Month

+25.97%

3 Months

+62.85%

6 Months

+165.84%

1 Year

+163.01%

52W Low

₹635

Current

₹1672

52W High

₹1999

76% of 52-week range — Near highs

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹1630

▲ Price above SMA 50 — Bullish

SMA 200

₹1396

▲ Long-term uptrend

Volume Signal

98% of avg

Average volume

Technical indicators are for educational purposes only. Not investment advice.

More on Fredun Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.